Berberine and Alcohol: What Is Known About Drinking While Taking It

What is known about berberine and alcohol

The evidence comes in three separate layers, and they should not be mixed up. The first is direct human evidence, meaning studies where people took both. We found none. The second is animal research, which is relevant to biology but does not tell you what happens in a person. The third is human data on berberine and the liver’s drug-handling enzymes, which is real human data but does not cover alcohol. The rest of this article keeps those layers apart.

Mouse studies: liver protection, not a green light

A 2020 study in Clinical and Translational Medicine gave male mice a diet containing 5% alcohol for several weeks plus three large alcohol doses by tube feeding, an experimental model of alcohol-related liver disease. Berberine given by tube at 10, 50 or 100 mg per kg of body weight lowered the liver enzymes ALT and AST in the blood and reduced fat build-up and inflammation in the liver ^[2]. The protection depended on gut bacteria: it disappeared in mice whose gut bacteria had been reduced with antibiotics, and transferring gut contents from berberine-treated mice improved liver injury in others ^[2].

The limits are substantial. Groups were small, about five mice each, only males were used, the authors acknowledge that a key immune-cell population was not fully characterised, and the work included no human testing ^[2]. A mouse eating alcohol for a month is a model of chronic liver injury, not of a person having a drink at the weekend. It gives no basis for saying that berberine protects a human liver from alcohol, and it equally gives no basis for saying that drinking is safe on berberine.

Liver enzymes: relevant to medicines, silent on alcohol

In a randomised crossover study of healthy men, 300 mg of berberine three times daily for two weeks reduced the activity of three liver enzymes in the cytochrome P450 family, which help the body break down many medicines. The ratio of dextromethorphan to its breakdown product, a test of CYP2D6, rose ninefold, the losartan ratio, a test of CYP2C9, doubled, and exposure to the CYP3A4 test drug midazolam was about 40% higher ^[1]. Two other enzymes, CYP2C19 and CYP1A2, showed no significant change ^[1]. EFSA’s 2026 draft assessment also reports that berberine may inhibit CYP3A4 ^[8]. Think of these enzymes as a processing queue: berberine in the queue can slow some medicines down.

These ratios measure enzyme activity, a pharmacokinetic change, and they are not a clinical outcome. The study was small, lasted two weeks and enrolled healthy men only. Whether a given change matters depends on the medicine involved: a drug that depends heavily on CYP3A4 or CYP2D6 for clearance is more likely to be affected than one cleared another way. The authors advise considering drug interactions when berberine is given ^[1].

The study tested five probe drugs, not alcohol. It therefore cannot tell you whether berberine changes how quickly the body clears alcohol or whether it alters the effects of a drink. We also found no human study of berberine and alcohol-related liver injury, which means the question “does berberine stress the liver if mixed with alcohol?” has no evidence-based answer in either direction. The NHS lists liver disease among the conditions whose risk rises when someone drinks more than 14 units a week over many years, and says there is no safe level of drinking ^[5].

Low blood sugar: the best-grounded concern

What alcohol does to blood sugar in people with diabetes

An NHS hospital-trust leaflet explains that alcohol lowers blood sugar and stops the liver correcting falling levels, which raises the risk of hypoglycaemia (a “hypo”, or low blood sugar). People taking insulin or sulphonylureas, a class of diabetes tablets that includes gliclazide, glipizide, glimepiride and tolbutamide, are at higher risk, and the leaflet says the raised risk “can last well into the next day” ^[3]. Drinkaware likewise states that drinking on an empty stomach increases the risk of hypos and that drinking heavily is very dangerous for people with diabetes, and lists dizziness, hunger, sweating, trembling, trouble concentrating and mood changes as common signs ^[4]. A hypo can be hard to tell apart from the effects of alcohol itself ^[3].

The leaflet’s practical advice is to eat starchy food before drinking, never to drink on an empty stomach, to snack on starchy food while drinking, to have a starchy snack before bed and to eat something starchy on waking ^[3]. For a severe hypo, the NHS advises calling 999 ^[4].

Where berberine fits

In a 2022 meta-analysis of 37 randomised trials, berberine was associated with lower fasting glucose (on average 0.82 mmol/L lower) in people with type 2 diabetes ^[7]. Hypoglycaemia was assessed in nine of those trials; only two reported any events, and the authors rated the certainty of that finding as very low, so it is neither reassurance nor a warning ^[7]. The NHS notes that low blood sugar mainly affects people with diabetes who take insulin or some other diabetes medicines ^[6].

Nobody has tested berberine and alcohol together for blood sugar. The reasoning for caution is therefore theoretical: two things that lower glucose by different routes may add up, and one of them can keep acting after a night of drinking. That is a mechanistic expectation, not a demonstrated outcome. It matters most for people already on insulin or sulphonylureas, who should ask their diabetes team before adding berberine at all.

A dose the morning after

One practical gap is worth naming. If you take berberine in the morning and drink the night before, that dose falls inside the window the NHS leaflet describes as carrying raised hypo risk for people on insulin or sulphonylureas ^[3]. No study has examined a morning-after berberine dose, so we cannot say whether it makes any difference. If you take diabetes medicines, that is a question for your pharmacist or diabetes team.

Claims about “liver support” and “detox”

Supplement pages sometimes present berberine as a way to protect the liver from alcohol or to recover after a heavy weekend. The evidence behind such claims is the mouse study above, which belongs to the weakest rung of the evidence ladder: a laboratory model that suggests a mechanism and nothing more. The model also involved a month of alcohol feeding plus three large binge doses by tube ^[2], far from a human drinking pattern. The Food Standards Agency says food supplements are not medicines and should not be sold with claims that they prevent, treat or cure a medical condition ^[9]. If a product page promises liver protection after drinking, treat it as marketing rather than as a finding.

Hangovers, nausea and the overlap problem

We found no study of berberine for hangovers, and no evidence that it makes a hangover better or worse. There is, however, an overlap worth knowing about. Berberine’s best-documented side effects are gut symptoms, with 34.5% of participants in a 2008 pilot trial reporting transient effects such as wind, diarrhoea, constipation and abdominal pain ^[10], and EFSA’s review lists nausea among the frequent effects ^[8]. Alcohol can also cause nausea and stomach upset. If you have both, you cannot tell which is responsible. For people with diabetes, the NHS leaflet notes that alcohol-related sickness can disrupt diabetes medicines and blood sugar ^[3].

Should you skip your berberine dose when drinking?

The evidence cannot answer this, because we found no comparison of taking and skipping a dose around drinking. What the sources do support is a set of general points. If you take insulin or a sulphonylurea, the NHS leaflet advice about eating before and after drinking applies regardless of berberine, and berberine is an additional reason to ask your team for individual advice ^[3]. For anyone, the NHS advises not regularly drinking more than 14 units a week and spreading drinking over three or more days, and says that 14 units is low risk, not safe ^[5].

Dosage context

There is no licensed UK dose of berberine, because supplements are regulated as food, and the Food Standards Agency advises following the label and not exceeding the recommended dose ^[9]. The enzyme study above used 300 mg three times daily for two weeks ^[1], and the mouse study used doses per kilogram of body weight that cannot be translated into a human dose ^[2]. No dose has been tested alongside alcohol in people.

Frequently asked questions

Editorial summary

There is no direct evidence on berberine and alcohol in people. The indirect evidence points in different directions: a mouse model suggests liver protection, a human enzyme study shows that berberine can slow the handling of some medicines, and clinical guidance on alcohol and diabetes medicines highlights low blood sugar. None of these is a tested combination, and each answers a different question.

For readers, the useful points are practical. People on insulin or sulphonylureas have the clearest reason for caution and should ask their diabetes team. Anyone taking prescribed medicines should check with a pharmacist. Other readers are working without data, and the NHS low-risk drinking guideline remains the sensible reference point. Evidence reviewed on 5 November 2026.

References

1. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. DOI 10.1007/s00228-011-1108-2. Springer record
2. Li S, Wang N, Tan H-Y, Chueng F, Zhang Z-J, Yuen M-F, Feng Y. Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease. Clin Transl Med. 2020;10:e112. Full text (University of Hong Kong repository)
3. University Hospitals Sussex NHS Foundation Trust. Diabetes and alcohol (patient information leaflet), 2024. NHS leaflet (PDF)
4. Drinkaware. Alcohol and diabetes. Drinkaware page
5. NHS. The risks of drinking too much. NHS Live Well
6. NHS. Low blood sugar (hypoglycaemia). NHS Health A to Z
7. Xie W, Su F, Wang G, et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045. Full text
8. European Food Safety Authority. EFSA’s draft opinion on the safety of plant preparations containing berberine: stakeholder webinar slides, 22 April 2026. EFSA slides (PDF)
9. Food Standards Agency. Food supplements guidance (consumers). GOV.UK, published 25 June 2026. GOV.UK guidance
10. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712–717. PubMed record